Igor Andrašina

1.3k total citations
12 papers, 54 citations indexed

About

Igor Andrašina is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Igor Andrašina has authored 12 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Hepatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Igor Andrašina's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Igor Andrašina is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Igor Andrašina collaborates with scholars based in Slovakia, Czechia and Poland. Igor Andrašina's co-authors include Ján Sabó, Michal Alexovič, Peter Kružliak, Rachele Ciccocioppo, Daniel Petrovič, Mariusz Adamek, Ivan Talian, Boris Rychlý, Sylvia Dražilová and Marek Rác and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Igor Andrašina

8 papers receiving 53 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Andrašina Slovakia	5	12	12	12	12	12	12	54
Jennifer K. Kerner United States	4	4 0.3×	7 0.6×	12 1.0×	17 1.4×	13 1.1×	5	70
Yoko Yoshimaru Japan	6	6 0.5×	14 1.2×	16 1.3×	24 2.0×	41 3.4×	16	61
Ahmed Adamu Nigeria	5	8 0.7×	16 1.3×	21 1.8×	6 0.5×	2 0.2×	14	63
J. Yu China	4	11 0.9×	11 0.9×	18 1.5×	14 1.2×	2 0.2×	4	50
Karin Choquette United States	3	23 1.9×	5 0.4×	35 2.9×	7 0.6×	3 0.3×	3	74
Kornelius Schulze Germany	4	9 0.8×	6 0.5×	14 1.2×	14 1.2×	16 1.3×	7	50
Y Okamura Japan	3	7 0.6×	7 0.6×	11 0.9×	6 0.5×	3 0.3×	5	45
Tobias Suske Austria	2	22 1.8×	10 0.8×	12 1.0×	20 1.7×	4 0.3×	3	65
Brenda Hernandez Spain	2	6 0.5×	6 0.5×	15 1.3×	16 1.3×	26 2.2×	2	44
Cuncai Zhou China	2	4 0.3×	12 1.0×	15 1.3×	6 0.5×	21 1.8×	3	30

Countries citing papers authored by Igor Andrašina

Since Specialization

Citations

This map shows the geographic impact of Igor Andrašina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Andrašina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Andrašina more than expected).

Fields of papers citing papers by Igor Andrašina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Andrašina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Andrašina. The network helps show where Igor Andrašina may publish in the future.

Co-authorship network of co-authors of Igor Andrašina

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Andrašina. A scholar is included among the top collaborators of Igor Andrašina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Andrašina. Igor Andrašina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Zhu, Jiang, Chee Khoon Lee, Isamu Okamoto, et al.. (2025). LBA77 FLAURA2: Exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC. Annals of Oncology. 36. S1618–S1619.

Dražilová, Sylvia, Jakub Gazda, Igor Andrašina, et al.. (2023). Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population. Current Oncology. 30(3). 3557–3570. 8 indexed citations

Dražilová, Sylvia, Jakub Gazda, Igor Andrašina, et al.. (2022). Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers. Journal of Clinical Medicine. 11(14). 4183–4183. 3 indexed citations

Dražilová, Sylvia, Jakub Gazda, Igor Andrašina, et al.. (2021). Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak Cohort. Journal of Clinical Medicine. 10(14). 3186–3186. 5 indexed citations

Andrašina, Igor, et al.. (2020). Systemic treatment for hepatocellular carcinoma. Klinicka onkologie. 33(5). 356–361. 1 indexed citations

Kasan, Peter, et al.. (2019). EP1.14-34 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study. Journal of Thoracic Oncology. 14(10). S1045–S1045.

Alexovič, Michal, et al.. (2019). Differential Urinary Proteomic Analysis of Endometrial Cancer. Physiological Research. 68(Suppl 4). S483–S490. 9 indexed citations

Kasan, Peter, et al.. (2018). P3.13-11 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study. Journal of Thoracic Oncology. 13(10). S980–S980.

Alexovič, Michal, Ivan Talian, Igor Andrašina, et al.. (2016). Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line. Journal of Cancer Research and Clinical Oncology. 143(1). 35–42. 20 indexed citations

10.

Andrašina, Igor, et al.. (2013). Enhancement of docetaxel-treated MCF-7 cell death by 900-MHz radiation. Open Life Sciences. 8(4). 357–365. 2 indexed citations

11.

Švajdler, Marián, et al.. (2012). Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literature.. PubMed. 48(1). 44–8. 5 indexed citations

12.

Chovanec, Josef, et al.. (2011). Combination of cetuximab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience.. Journal of Clinical Oncology. 29(4_suppl). 622–622. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact